SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

AXSM

Axsome Therapeutics, Inc.
NASDAQHealth Care

Latest close: 157.14 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 3, 2026Reported sale · Form 4Mark L. Jacobson, Chief Operating Officer · $2.1MOpen the filing ↗
  2. Sep 3, 2026Notice of sale · Form 144Mark Jacobson · Officer · $2.1MOpen the filing ↗
  3. Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record6417 flagged findings
Reported transactions (Form 4)80since Dec 4, 2025 · and 3 other holdings
Corporate events (8-K)30since Dec 5, 2019

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

American biopharmaceutical company

Source: Wikidata (CC0 1.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-04share offering or dilution eventrecentOpen filing ↗
    “…of these matters, individually or in the aggregate, will have a material adverse effect on its financial position. As of March 31,…”
    +1 more passage from the same document
    • “…also include $70.0 million in gross proceeds from the Blackstone revolving credit facilities and $70.0 million in repayments for…”
  • 2026-05-04Department of Justice inquiryrecentOpen filing ↗
    “…and any of our collaborators, must comply with laws, regulations, and other requirements concerning advertising and promotion for…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 641)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 3, 26Form 144 ↗Notice of proposed sale
  • Sep 3, 26Form 4 ↗Insider transaction
  • Aug 10, 2610-Q ↗Quarterly report
  • Aug 10, 268-K ↗Current report · Results · Other events
  • Aug 7, 26Form 4 ↗Insider transaction
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Jul 27, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 5.3% · event on Jun 30, 26 · amendment
  • Jul 15, 268-K ↗Current report · Other events
  • Jul 1, 26Form 144 ↗Notice of proposed sale
  • Jul 1, 26Form 4 ↗Insider transaction
  • Jun 11, 26Form 144 ↗Notice of proposed sale
  • Jun 11, 26Form 4 ↗Insider transaction
  • Notice of proposed sale · 3 Form 144 filingsshow all 3hide
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Notice of proposed sale · 3 Form 144 filingsshow all 3hide
  • Jun 9, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 9, 268-K ↗Current report · Shareholder vote results

641 filings on record, the oldest from Sep 22, 15.

Listing the 25 most recent filings of the 641 on record.

8-Ks, explained

Stress1Structure38Governance12
  • Jun 9, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 13, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Oct 1, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Oct 11, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 26, 23GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Jun 8, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 22, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 9, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Nov 14, 22StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • May 9, 22StructureCompleted an acquisition or disposal+4 more in the same filing8-K 2.01 ↗
  • Structure5 material agreements entered2020 – 2022show all 5hide
    • Mar 31, 22StructureEntered a material agreement+1 more in the same filing8-K/A 1.01 ↗
    • Mar 28, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 1, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Oct 18, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Sep 29, 20StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2020show all 4hide
    • Sep 8, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 8, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 21, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 5, 20GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

2 older filings not shown · The record reaches back to Jul 12, 16.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Jul 12, 16StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 1 stress filing.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.5.3%Jun 30, 26SCHEDULE 13G/A ↗
  • RTW Investments, LP3.1%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 3, Mark Jacobson filed notice of intent to sell up to $2.1M. That is about 0.02% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $2.1M on Sep 3, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+3 more recent notices · 3 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 3, 26Sell$2.1MMark L. JacobsonChief Operating Officer↗
  • Aug 6, 26Sell$997KHERRIOT TABUTEAUChief Executive Officer↗
  • Aug 5, 26Sell$9.5MHERRIOT TABUTEAUChief Executive Officer↗
  • Jul 1, 26Sell$11.9MHERRIOT TABUTEAUChief Executive Officer↗
  • Jun 11, 26Sell$71KROGER JEFFS↗
  • Jun 10, 26Sell$160KMark Coleman↗
  • Jun 10, 26Sell$74KSusan Mahony↗
  • Jun 10, 26Sell$70KROGER JEFFS↗
  • Jun 9, 26Sell$7.9MNick PizzieChief Financial Officer↗
  • Jun 9, 26Sell$12.0MHERRIOT TABUTEAUChief Executive Officer↗
  • Jun 9, 26Sell$71KSusan Mahony↗
  • Jun 2, 26Sell$1.2MMark Coleman↗

There are 9 more transactions in this stretch.

Stock compensation, tax and giftsshow the 19 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 3, 26Compensation$130KMark L. JacobsonChief Operating Officer↗
  • Aug 6, 26Compensation$23KHERRIOT TABUTEAUChief Executive Officer↗
  • Aug 5, 26Compensation$223KHERRIOT TABUTEAUChief Executive Officer↗
  • Jul 1, 26Compensation$246KHERRIOT TABUTEAUChief Executive Officer↗
  • Jun 9, 26Compensation$116KNick PizzieChief Financial Officer↗
  • Jun 9, 26Compensation$246KHERRIOT TABUTEAUChief Executive Officer↗
  • Jun 8, 26Compensationamount n/aMark Coleman↗
  • Jun 8, 26Compensationamount n/aSusan Mahony↗
  • Jun 8, 26Compensationamount n/aMark E Saad↗
  • Jun 8, 26Compensationamount n/aROGER JEFFS↗
  • May 5, 26Compensation$3KMark L. JacobsonChief Operating Officer↗
  • May 4, 26Compensation$58KMark L. JacobsonChief Operating Officer↗
  • Apr 22, 26Compensation$530KAri MaizelChief Commercial Officer↗
  • Feb 26, 26Compensation$101KMark L. JacobsonChief Operating Officer↗
  • Feb 23, 26Compensation$31KMark Coleman↗
  • Feb 20, 26Compensation$62KMark Coleman↗
  • Feb 10, 26Compensation$42KMark Coleman↗
  • Feb 2, 26Compensation$260KHERRIOT TABUTEAUChief Executive Officer↗
  • Jan 22, 26Compensation$42KNick PizzieChief Financial Officer↗

The full record holds 138 transactions and goes back to Jan 3, 23.

Its sector and its market

Axsome Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Axsome Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Axsome Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
641 documents on file, from Sep 22, 2015 to Sep 3, 2026.
Company description
Wikidata, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.